XML 35 R19.htm IDEA: XBRL DOCUMENT v3.3.1.900
Shareholders' Equity
12 Months Ended
Dec. 31, 2015
Stockholders' Equity Note [Abstract]  
Equity
Note 11 - Shareholders' Equity
The following table shows the changes in preferred and common stock issued and common stock held as treasury shares for the three years ended December 31, 2015.
 
 
(shares in thousands)
Series A Preferred Stock Issued
 
Series C Preferred Stock Issued
 
Common
Stock
Issued
 
Treasury
Stock
Held
 
Common Stock Outstanding
Balance at December 31, 2012
968

 

 
113,182

 
813

 
112,369

Settlement of prepaid common stock purchase contracts

 

 
17,550

 

 
17,550

Issuance of common stock

 

 
8,553

 

 
8,553

Restricted share unit activity

 

 
374

 

 
374

Stock options exercised

 

 
62

 

 
62

Issuance of Series C Preferred Stock

 
5,200

 

 

 

Redemption of Series A Preferred Stock
(968
)
 

 

 

 

Balance at December 31, 2013

 
5,200

 
139,721

 
813

 
138,908

Restricted share unit activity

 

 
52

 

 
52

Stock options exercised

 

 
177

 

 
177

Repurchase of common stock

 

 

 
3,014

 
(3,014
)
Balance at December 31, 2014

 
5,200

 
139,950

 
3,827

 
136,123

Restricted share unit activity

 

 
304

 

 
304

Stock options exercised

 

 
338

 

 
338

Repurchase of common stock

 

 

 
7,218

 
(7,218
)
Balance at December 31, 2015

 
5,200

 
140,592

 
11,045

 
129,547

 
 
 
 
 
 
 
 
 
 


Repurchases of Common Stock
During the third quarter of 2015, Synovus completed its $250 million share repurchase program which was announced on October 21, 2014 and expired on October 23, 2015. Under this program, Synovus repurchased 9.1 million shares of common stock through a combination of share repurchases under the accelerated share repurchase (ASR) agreement described below and open market transactions. Synovus entered into an ASR agreement during October 2014 to purchase $75.0 million of Synovus common stock under the share repurchase program. During 2014, Synovus repurchased 2.5 million shares of common stock under the ASR agreement. During January 2015, Synovus repurchased 392 thousand shares upon completion of the ASR agreement. Additionally, from October 2014 through September 30, 2015, Synovus repurchased $175.0 million, or 6.2 million shares, of common stock through open market transactions, including $161.9 million, or 5.7 million shares, of common stock repurchased during 2015.
During the third quarter of 2015, Synovus' Board of Directors authorized a $300 million share repurchase program to be completed over the next 15 months. During the fourth quarter of 2015, under the new $300 million share repurchase program, Synovus repurchased $37.1 million, or 1.2 million shares. At December 31, 2015, the remaining authorization under this program is $262.9 million.
Reverse Stock Split and Increase in Number of Authorized Common Shares
On April 24, 2014, at Synovus' 2014 annual shareholders' meeting, Synovus’ shareholders approved a proposal authorizing Synovus’ Board of Directors to effect a one-for-seven reverse stock split of Synovus’ common stock. Following this annual meeting, Synovus’ Board of Directors authorized the one-for-seven reverse stock split. The reverse stock split became effective on May 16, 2014, and Synovus' shares of common stock began trading on a post-split basis on the NYSE at the opening of trading on May 19, 2014. All prior periods presented in this Report have been adjusted to reflect the one-for-seven reverse stock split. Financial information updated by this capital change includes earnings per common share, dividends per common share, stock price per common share, weighted average common shares, outstanding common shares, treasury shares, common stock, additional paid-in capital, and share-based compensation.
Additionally, at Synovus' 2014 annual shareholders' meeting, Synovus’ shareholders approved an amendment to the articles of incorporation to increase the number of authorized shares of Synovus’ common stock from 1.2 billion shares to 2.4 billion shares. Synovus effected the increase in the number of authorized shares on April 24, 2014. Upon the reverse stock split effective date, the number of Synovus’ authorized shares of common stock was proportionately reduced from 2.4 billion shares to 342.9 million shares.